SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories trades lower on the bourses

23 Nov 2012 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 503.80, down by 8.90 points or 1.74% from its previous closing of Rs. 512.70 on the BSE.

The scrip opened at Rs. 514.95 and has touched a high and low of Rs. 514.95 and Rs. 503.20 respectively. So far 58136 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 578.30 on 04-Sep-2012 and a 52 week low of Rs. 366.50 on 19-Dec-2011.

Last one week high and low of the scrip stood at Rs. 525.00 and Rs. 499.70 respectively. The current market cap of the company is Rs. 21527.15 crore.

The promoters holding in the company stood at 63.64% while Institutions and Non-Institutions held 21.20% and 13.15% respectively.

Ranbaxy Laboratories has recalled Atorvastatin from the USA market which will cause temporary disruption to the market of this product. The investigation with regard to the same of this issue is expected to be completed within two weeks and thereafter the company expects to resume supplies.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×